Annual Report

Overview

The report presents Vistin Pharma's 2021 performance as a single-segment metformin business, with record production close to 3,700 MT and total revenue and income of MNOK 278.6. The Group ended the year with 74 employees and reported no TRI for the consecutive last five years. Sustainability initiatives included continued use of hydro-powered energy, a hydrocarbon-condensing cooling project, and an ambition to reduce greenhouse-gas emissions to air by 90% within the 2022-2025 ESG horizon.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2021
Period: Ends 31 December 2021
Language: English
Pages
File size

Standards

Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services